(KMI) Kinder Morgan - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US49456B1017
Stock: Natural Gas pipelines, Products pipelines, Terminals, CO2 pipelines
Total Rating 55
Risk 88
Buy Signal 0.09
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.30% |
| Yield on Cost 5y | 10.53% |
| Yield CAGR 5y | 2.10% |
| Payout Consistency | 95.0% |
| Payout Ratio | 70.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.5% |
| Relative Tail Risk | -5.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.51 |
| Alpha | 3.34 |
| Character TTM | |
|---|---|
| Beta | 0.518 |
| Beta Downside | 0.893 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.40% |
| CAGR/Max DD | 1.35 |
Description: KMI Kinder Morgan January 28, 2026
Kinder Morgan Inc. (KMI) is a North-American energy-infrastructure operator organized into four segments: Natural Gas Pipelines, Products Pipelines, Terminals, and CO₂. The company owns and runs a broad network of interstate and intrastate pipelines, storage facilities, LNG/LNG-related assets, refined-product pipelines, bulk terminals, and CO₂ capture and transport systems that support both conventional oil recovery and emerging renewable-natural-gas (RNG) projects.
As of the latest FY 2025 filing, KMI reported adjusted EBITDA of $14.2 billion, a pipeline utilization rate of 93 % for its natural-gas system, and a dividend yield of roughly 3.5 %. Key sector drivers include sustained U.S. natural-gas demand growth (≈2 % YoY), expanding LNG export capacity, and rising CO₂-enhanced oil recovery activity, which together underpin the company’s revenue outlook through 2027.
For a deeper quantitative view, you may want to explore ValueRay’s analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 3.06b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.76 > 1.0 |
| NWC/Revenue: -11.78% < 20% (prev -17.12%; Δ 5.33% < -1%) |
| CFO/TA 0.08 > 3% & CFO 5.74b > Net Income 3.06b |
| Net Debt (31.76b) to EBITDA (7.48b): 4.25 < 3 |
| Current Ratio: 0.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.23b) vs 12m ago 0.23% < -2% |
| Gross Margin: 43.66% > 18% (prev 0.37%; Δ 4330 % > 0.5%) |
| Asset Turnover: 23.52% > 50% (prev 21.11%; Δ 2.41% > 0%) |
| Interest Coverage Ratio: 2.79 > 6 (EBITDA TTM 7.48b / Interest Expense TTM 1.80b) |
Altman Z'' -0.18
| A: -0.03 (Total Current Assets 63.0m - Total Current Liabilities 2.06b) / Total Assets 72.75b |
| B: -0.14 (Retained Earnings -10.52b / Total Assets 72.75b) |
| C: 0.07 (EBIT TTM 5.03b / Avg Total Assets 72.08b) |
| D: 0.00 (Book Value of Equity 45.0m / Total Liabilities 40.30b) |
| Altman-Z'' Score: -0.18 = B |
What is the price of KMI shares?
As of February 06, 2026, the stock is trading at USD 30.06 with a total of 18,760,170 shares traded.
Over the past week, the price has changed by +0.94%, over one month by +8.79%, over three months by +17.46% and over the past year by +14.02%.
Over the past week, the price has changed by +0.94%, over one month by +8.79%, over three months by +17.46% and over the past year by +14.02%.
Is KMI a buy, sell or hold?
Kinder Morgan has received a consensus analysts rating of 3.90.
Therefore, it is recommended to buy KMI.
- StrongBuy: 8
- Buy: 3
- Hold: 8
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.7 | 5.4% |
| Analysts Target Price | 31.7 | 5.4% |
| ValueRay Target Price | 37.1 | 23.5% |
KMI Fundamental Data Overview January 31, 2026
P/E Trailing = 22.073
P/E Forward = 22.2222
P/S = 3.9722
P/B = 2.1589
P/EG = 3.5576
Revenue TTM = 16.95b USD
EBIT TTM = 5.03b USD
EBITDA TTM = 7.48b USD
Long Term Debt = 30.78b USD (from longTermDebt, last quarter)
Short Term Debt = 1.23b USD (from shortTermDebt, last quarter)
Debt = 31.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 31.76b USD (from netDebt column, last quarter)
Enterprise Value = 99.04b USD (67.28b + Debt 31.82b - CCE 63.0m)
Interest Coverage Ratio = 2.79 (Ebit TTM 5.03b / Interest Expense TTM 1.80b)
EV/FCF = 35.97x (Enterprise Value 99.04b / FCF TTM 2.75b)
FCF Yield = 2.78% (FCF TTM 2.75b / Enterprise Value 99.04b)
FCF Margin = 16.24% (FCF TTM 2.75b / Revenue TTM 16.95b)
Net Margin = 18.03% (Net Income TTM 3.06b / Revenue TTM 16.95b)
Gross Margin = 43.66% ((Revenue TTM 16.95b - Cost of Revenue TTM 9.55b) / Revenue TTM)
Gross Margin QoQ = 67.90% (prev 32.71%)
Tobins Q-Ratio = 1.36 (Enterprise Value 99.04b / Total Assets 72.75b)
Interest Expense / Debt = 1.39% (Interest Expense 442.0m / Debt 31.82b)
Taxrate = 21.76% (284.0m / 1.30b)
NOPAT = 3.93b (EBIT 5.03b * (1 - 21.76%))
Current Ratio = 0.03 (Total Current Assets 63.0m / Total Current Liabilities 2.06b)
Debt / Equity = 1.02 (Debt 31.82b / totalStockholderEquity, last quarter 31.16b)
Debt / EBITDA = 4.25 (Net Debt 31.76b / EBITDA 7.48b)
Debt / FCF = 11.54 (Net Debt 31.76b / FCF TTM 2.75b)
Total Stockholder Equity = 30.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.24% (Net Income 3.06b / Total Assets 72.75b)
RoE = 9.92% (Net Income TTM 3.06b / Total Stockholder Equity 30.82b)
RoCE = 8.16% (EBIT 5.03b / Capital Employed (Equity 30.82b + L.T.Debt 30.78b))
RoIC = 6.21% (NOPAT 3.93b / Invested Capital 63.34b)
WACC = 5.66% (E(67.28b)/V(99.10b) * Re(7.83%) + D(31.82b)/V(99.10b) * Rd(1.39%) * (1-Tc(0.22)))
Discount Rate = 7.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.09%
[DCF Debug] Terminal Value 86.12% ; FCFF base≈3.23b ; Y1≈3.17b ; Y5≈3.22b
Fair Price DCF = 28.94 (EV 96.15b - Net Debt 31.76b = Equity 64.39b / Shares 2.22b; r=5.90% [WACC]; 5y FCF grow -3.05% → 2.90% )
EPS Correlation: 37.28 | EPS CAGR: 12.43% | SUE: 4.0 | # QB: 1
Revenue Correlation: -34.84 | Revenue CAGR: 0.44% | SUE: 0.23 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=-0.005 | Revisions Net=+0 | Analysts=8
EPS current Year (2026-12-31): EPS=1.36 | Chg30d=-0.026 | Revisions Net=-2 | Growth EPS=+4.7% | Growth Revenue=+5.1%
EPS next Year (2027-12-31): EPS=1.46 | Chg30d=-0.007 | Revisions Net=-3 | Growth EPS=+7.5% | Growth Revenue=+5.5%
P/E Forward = 22.2222
P/S = 3.9722
P/B = 2.1589
P/EG = 3.5576
Revenue TTM = 16.95b USD
EBIT TTM = 5.03b USD
EBITDA TTM = 7.48b USD
Long Term Debt = 30.78b USD (from longTermDebt, last quarter)
Short Term Debt = 1.23b USD (from shortTermDebt, last quarter)
Debt = 31.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 31.76b USD (from netDebt column, last quarter)
Enterprise Value = 99.04b USD (67.28b + Debt 31.82b - CCE 63.0m)
Interest Coverage Ratio = 2.79 (Ebit TTM 5.03b / Interest Expense TTM 1.80b)
EV/FCF = 35.97x (Enterprise Value 99.04b / FCF TTM 2.75b)
FCF Yield = 2.78% (FCF TTM 2.75b / Enterprise Value 99.04b)
FCF Margin = 16.24% (FCF TTM 2.75b / Revenue TTM 16.95b)
Net Margin = 18.03% (Net Income TTM 3.06b / Revenue TTM 16.95b)
Gross Margin = 43.66% ((Revenue TTM 16.95b - Cost of Revenue TTM 9.55b) / Revenue TTM)
Gross Margin QoQ = 67.90% (prev 32.71%)
Tobins Q-Ratio = 1.36 (Enterprise Value 99.04b / Total Assets 72.75b)
Interest Expense / Debt = 1.39% (Interest Expense 442.0m / Debt 31.82b)
Taxrate = 21.76% (284.0m / 1.30b)
NOPAT = 3.93b (EBIT 5.03b * (1 - 21.76%))
Current Ratio = 0.03 (Total Current Assets 63.0m / Total Current Liabilities 2.06b)
Debt / Equity = 1.02 (Debt 31.82b / totalStockholderEquity, last quarter 31.16b)
Debt / EBITDA = 4.25 (Net Debt 31.76b / EBITDA 7.48b)
Debt / FCF = 11.54 (Net Debt 31.76b / FCF TTM 2.75b)
Total Stockholder Equity = 30.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.24% (Net Income 3.06b / Total Assets 72.75b)
RoE = 9.92% (Net Income TTM 3.06b / Total Stockholder Equity 30.82b)
RoCE = 8.16% (EBIT 5.03b / Capital Employed (Equity 30.82b + L.T.Debt 30.78b))
RoIC = 6.21% (NOPAT 3.93b / Invested Capital 63.34b)
WACC = 5.66% (E(67.28b)/V(99.10b) * Re(7.83%) + D(31.82b)/V(99.10b) * Rd(1.39%) * (1-Tc(0.22)))
Discount Rate = 7.83% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.09%
[DCF Debug] Terminal Value 86.12% ; FCFF base≈3.23b ; Y1≈3.17b ; Y5≈3.22b
Fair Price DCF = 28.94 (EV 96.15b - Net Debt 31.76b = Equity 64.39b / Shares 2.22b; r=5.90% [WACC]; 5y FCF grow -3.05% → 2.90% )
EPS Correlation: 37.28 | EPS CAGR: 12.43% | SUE: 4.0 | # QB: 1
Revenue Correlation: -34.84 | Revenue CAGR: 0.44% | SUE: 0.23 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.37 | Chg30d=-0.005 | Revisions Net=+0 | Analysts=8
EPS current Year (2026-12-31): EPS=1.36 | Chg30d=-0.026 | Revisions Net=-2 | Growth EPS=+4.7% | Growth Revenue=+5.1%
EPS next Year (2027-12-31): EPS=1.46 | Chg30d=-0.007 | Revisions Net=-3 | Growth EPS=+7.5% | Growth Revenue=+5.5%